4-traders.com, stock quotes, stock exchange, market price, stock market advice, technical analysis, stock chart analysis, Company News
September 3, 2010 01:31 pm US/Eastern
Search
Dynamic quotes   
On
 | Off
  • Technical Analysis
  • Market Quotes
  • Market News
  • Market Screeners and Tools

4-Traders Homepage  >  Shares  >  Nasdaq  >  CEPHALON   CEPH   US1567081096

CEPHALON (CEPH)

  
Real time Streaming quotes -
Delayed Quote. Delayed Nasdaq - 09/03 01:16:19 pm
60.32 USD   +0.60%
08/25CEPHALON: Announces Chairman and CEO to Take Medical Leave of Absence
07/27CEPHALON: Reports Record Sales and Earnings in Second Quarter 2010
07/21CEPHALON: Expects Second Quarter 2010 Results to Exceed Previously Issued Guida..
 SummaryQuotesChart AnalysisNewsCalendarCompanyFundamentalsConsensus
Quotes 5-day view   Delayed Quote. Delayed Nasdaq - 09/03 01:16:19 pm
08/30/2010 08/31/2010 09/01/2010 09/02/2010 09/03/2010 Date
56.79(c) 56.61(c) 59.42(c) 59.96(c) 60.32 Last
544 680 1 129 644 1 937 931 937 839 465 132 Volume
-0.89% -0.32% +4.96% +0.91% +0.60% Change
More quotes
Fundamentals ($)
Revenue 2010 2 756 M
EBIT 2010 910,0 M
Net Profit 2010 438,3 M
Trésorie 2010 264,5 M
Yield 2010 -
Revenue 2011 2 966 M
EBIT 2011 948,4 M
Net Profit 2011 505,3 M
Trésorie 2011 610,8 M
Yield 2011 -
PER 2010 12,07
PER 2011 9,99
VE / Revenue 2010 1,54x
VE / Revenue 2011 1,31x
Capitalization 4 509 M
More Fundamentals
Sector
Biotechnology
Calendar

- Aucun évènement disponible -

Business Summary
Cephalon specializes in the research, development, manufacturing and marketing of therapeutic products. Net sales break down by source of income as follows: - sale of drugs (98.1%): intended for the treatment of neurological dysfunction (53.7% of...
Read more
Latest news on CEPHALON
08/25CEPHALON: Announces Chairman and CEO to Take Medical Leave of Absence
07/27CEPHALON: Reports Record Sales and Earnings in Second Quarter 2010
07/21CEPHALON: Expects Second Quarter 2010 Results to Exceed Previously Issued Guida..
06/24CEPHALON: Second Quarter 2010 Earnings Conference Call Tuesday, July 27, 2010 a..
06/21CEPHALON: Celator® Pharmaceuticals Expands Research Agreement With Cephalon, In..
06/02CEPHALON: Provides Clinical Update on Phase II Study of NUVIGIL as an Adjunctiv..
05/04CEPHALON: off to Record Start in 2010
04/09CEPHALON: Completes Acquisition of Swiss Pharmaceutical Company Mepha
04/05CEPHALON: Completes Acquisition of Ception Therapeutics
03/31CEPHALON: First Quarter 2010 Earnings Conference Call Tuesday, May 4, 2010 at 5..
03/29CEPHALON: Receives Complete Response Letter for NUVIGIL for the Treatment of Ex..
02/23CEPHALON: Exercises its Option to Acquire Ception Therapeutics
More news
Chart CEPHALON
Short term
Mid-term
Long term
Graphique historique des cours de bourse de CEPHALON
Full-screen chart
Trends chart analysis
Short termMid-termLong term
BullishBearishBearish
Chart Analysis
Income Statement Evolution
CEPHALON : Income Statement Evolution
More Fundamentals
EPS Reviews
CEPHALON : EPS Reviews
More Estimates Reviews
Price share CEPHALON (USA), Source for Financial Market Quotes, Charts, Technical Analysis and Consensus. Stock market quotes including the latest stock price , stock market quote for the NASDAQ 100, news and fundamental investing data and price charts. The easy way to get information on stocks, currencies, indexes, commodities , certicates, and Warrants. Contact us ¤ Site map
Quotes are delayed 15 minutes for Nasdaq, Nyse and Euronext. Dow Jones indexes from Dow Jones & Company and Nasdaq indexes are 15 minutes delayed. CAC 40, Forex and Tradegate exchange are in real-time. Others exchanges are in end of day. Data are provided by Interactive Data - Tijd Beursmedia.
Copyright ©  2001 - 2010 Surperformance SAS /